Amgen Inc

NASDAQ:AMGNUnited States

Apr 30, 2024

Show headlines and story abstract

• Sector Update: Health Care Stocks Mixed Premarket Tuesday, from 9:20AM ET on Tuesday Apr 30, 2024 by MT Newswires

  9:20AM ET on Tuesday Apr 30, 2024 by MT Newswires
  Companies Mentioned: IBB, LLY, XLV, AMGN
  09:20 AM EDT, 04/30/2024 (MT Newswires) -- Health care stocks were mixed premarket Tuesday, with the iShares Biotechnology ETF (IBB) down 0.3% and Health Care Select Sector SPDR Fund (XLV) up 0.3%. Eli Lilly (LLY) shares were up over 5% after the co...

• Amgen Reaches Deal to Resolve Patent Disputes With Sandoz, from 5:58AM ET on Tuesday Apr 30, 2024 by MT Newswires

  5:58AM ET on Tuesday Apr 30, 2024 by MT Newswires
  Companies Mentioned: AMGN
  05:58 AM EDT, 04/30/2024 (MT Newswires) -- Amgen (AMGN) and Sandoz reached an agreement to resolve their patent disputes related to Sandoz's denosumab biosimilars, according to a Tuesday statement from Sandoz. In May 2023 patent infringement proceed...

• *DJ Sandoz Reaches Agreement With Amgen Resolving All Patent Litigation, from 1:02AM ET on Tuesday Apr 30, 2024 by Dow Jones

  1:02AM ET on Tuesday Apr 30, 2024 by Dow Jones
  Companies Mentioned: AMGN
  
  By Ian Walker
  
  Sandoz Group said that it has reached agreement with Amgen in the patent dispute over the company's denosumab biosimilars products, paving the way for it to launch its bone treatments Jubbonti and Wyost in the U.S. by May 31.